| Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors (NCT01479023) | Washington University School of Medicine | 2012-04-01 |
| Assessment of Patient Experience During Treatment for Cancer (NCT01553825) | Stanford University | 2012-03-01 |
| S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) (NCT01533324) | Second Military Medical University | 2011-11-01 |
| Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. (NCT01398306) | University Medical Center Groningen | 2011-07-01 |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma (NCT01339975) | University Hospital, Bordeaux | 2011-06-06 |
| Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer (NCT01061515) | Washington University School of Medicine | 2011-05-10 |
| Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) (NCT01301612) | Eurofarma Laboratorios S.A. | 2011-01-01 |
| Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract (NCT01361100) | Centre Leon Berard | 2010-12-01 |
| Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer (NCT01253681) | Amgen | 2010-11-01 |
| Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC (NCT01214343) | Ministry of Health, Labour and Welfare, Japan | 2010-10-01 |
| Study of MOC31-PE in Antigen Positive Carcinomas (NCT01061645) | Oslo University Hospital | 2010-09-01 |
| A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma (NCT01223209) | Lytix Biopharma AS | 2010-08-01 |
| Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer (NCT01109524) | Eli Lilly and Company | 2010-07-01 |
| Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. (NCT01035229) | Novartis Pharmaceuticals | 2010-04-01 |
| Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma (NCT01097083) | National University Hospital, Singapore | 2010-04-01 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |
| Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions. (NCT01043523) | Bayer | 2009-12-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer (NCT01016054) | Astellas Pharma Inc | 2009-10-01 |
| RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe (NCT00688753) | Novartis Pharmaceuticals | 2009-07-01 |
| Molecular Biology of Anal Cancer in HIV-Positive Patients (NCT00952874) | University Hospital, Geneva | 2009-07-01 |
| Paclitaxel/Carboplatin With or Without Cetuximab in CUP (NCT00894569) | Heidelberg University | 2009-07-01 |
| RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe (NCT00688623) | Novartis Pharmaceuticals | 2009-06-24 |
| Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma (NCT01149161) | Samsung Medical Center | 2009-05-01 |
| A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC). (NCT00863746) | Bayer | 2009-04-01 |
| A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer (NCT00781911) | Eli Lilly and Company | 2009-02-01 |
| Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer (NCT00838201) | Amgen | 2009-02-01 |
| AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR (NCT00770536) | Amgen | 2009-01-01 |
| Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) (NCT00599755) | Merck Sharp & Dohme LLC | 2009-01-01 |
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers (NCT00822809) | Neovii Biotech | 2008-12-01 |
| Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer (NCT00719264) | Novartis Pharmaceuticals | 2008-11-12 |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma (NCT00752570) | Amgen | 2008-11-01 |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer (NCT00816764) | Astellas Pharma Inc | 2008-10-01 |
| Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site (NCT00737243) | SCRI Development Innovations, LLC | 2008-08-01 |
| Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients (NCT00728130) | Southern Illinois University | 2008-05-01 |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer (NCT00742222) | Xoft, Inc. | 2008-05-01 |
| Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer (NCT00804830) | Region Skane | 2008-04-01 |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer (NCT00672009) | Cedars-Sinai Medical Center | 2008-04-01 |
| Evaluation of the Bonfils Fiberscope for Predicted Difficult Intubation in Awake Patients With Ear, Nose, and Throat (ENT) Cancer (INVIBO) (NCT01070537) | Centre Leon Berard | 2008-02-01 |
| A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma (NCT00613691) | Spectrum Pharmaceuticals, Inc | 2008-01-01 |
| A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients (NCT00613652) | AstraZeneca | 2008-01-01 |
| Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors (NCT00879684) | Pfizer | 2008-01-01 |
| Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy (NCT00396617) | University Hospital, Strasbourg, France | 2007-12-01 |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) (NCT00446446) | Amgen | 2007-10-30 |
| A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NCT00532155) | Sanofi | 2007-09-01 |
| A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer (NCT00557596) | Aegera Therapeutics | 2007-09-01 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab (NCT00477425) | Genentech, Inc. | 2007-06-01 |
| Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma (NCT00466583) | Enzon Pharmaceuticals, Inc. | 2007-03-01 |
| A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors (NCT00879554) | Pfizer | 2007-02-01 |
| Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors (NCT00447005) | Pfizer | 2007-02-01 |
| Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer (NCT00420381) | Eli Lilly and Company | 2007-01-01 |
| Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases (NCT00327652) | Anza Therapeutics, Inc. | 2006-10-01 |
| The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer (NCT00243347) | AstraZeneca | 2005-12-01 |
| A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer (NCT00152477) | UCB Pharma | 2005-08-15 |
| ZD6474(Vandetanib) + Alimta Combo Study (NCT00506051) | Genzyme, a Sanofi Company | 2005-07-01 |
| Molecular Profiling in Lung Cancer Patients (NCT00191308) | Eli Lilly and Company | 2005-05-01 |
| Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors (NCT00731861) | Indiana University | 2005-05-01 |
| Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer (NCT01215500) | University of Chicago | 2005-01-01 |
| ARQ 501 in Combination With Docetaxel in Patients With Cancer (NCT00099190) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2004-12-01 |
| Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer (NCT00097903) | BioNumerik Pharmaceuticals, Inc. | 2004-05-01 |
| Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis (NCT00216372) | Ipsen | 2003-09-01 |
| Colonoscope Passive Bending Function (NCT00518349) | Norwegian Department of Health and Social Affairs | 2003-08-01 |
| Automated Telephone Monitoring for Symptom Management (NCT00799084) | Michigan State University | 2003-04-01 |
| Pain and Fatigue Study (NCT00006253) | Michigan State University | 2003-03-01 |
| Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. (NCT00364455) | Janssen-Ortho Inc., Canada | 2002-12-01 |
| Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006) (NCT00941863) | Bayer | 2002-07-01 |
| Darbepoetin Alfa and Anemia of Cancer (NCT00989092) | Amgen | 2002-05-01 |
| Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma (NCT00111774) | Amgen | 2002-03-01 |
| Collection of Blood and Urine From Patients Undergoing Radiation Therapy (NCT00027326) | National Cancer Institute (NCI) | 2001-12-02 |
| Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases (NCT00129051) | Alberta Health services | 2001-08-01 |
| Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) (NCT00183742) | University of Southern California | 2000-12-01 |
| Iressa Expanded Access Program (EAP) (NCT00034879) | AstraZeneca | 2000-08-01 |
| Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer (NCT00301548) | European Institute of Oncology | 2000-02-01 |
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis (NCT00001569) | National Cancer Institute (NCI) | 1997-01-01 |
| Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC (NCT06841874) | Nuvation Bio Inc. | |
| An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer (NCT02784158) | Ariad Pharmaceuticals | |